QIPT vs. HTL, OGI, CPH, CRDL, FRX, MDNA, DR, EDT, VHI, and HLS
Should you be buying Quipt Home Medical stock or one of its competitors? The main competitors of Quipt Home Medical include Hamilton Thorne (HTL), Organigram (OGI), Cipher Pharmaceuticals (CPH), Cardiol Therapeutics (CRDL), Fennec Pharmaceuticals (FRX), Medicenna Therapeutics (MDNA), Medical Facilities (DR), Spectral Medical (EDT), Vitalhub (VHI), and HLS Therapeutics (HLS). These companies are all part of the "medical" sector.
Hamilton Thorne (TSE:HTL) and Quipt Home Medical (TSE:QIPT) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, profitability, dividends, community ranking, risk, analyst recommendations and media sentiment.
Quipt Home Medical has a consensus target price of C$11.74, indicating a potential upside of 117.41%. Given Hamilton Thorne's stronger consensus rating and higher possible upside, analysts plainly believe Quipt Home Medical is more favorable than Hamilton Thorne.
In the previous week, Hamilton Thorne had 2 more articles in the media than Quipt Home Medical. MarketBeat recorded 3 mentions for Hamilton Thorne and 1 mentions for Quipt Home Medical. Quipt Home Medical's average media sentiment score of 0.00 equaled Hamilton Thorne'saverage media sentiment score.
Hamilton Thorne has higher earnings, but lower revenue than Quipt Home Medical. Hamilton Thorne is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.
Quipt Home Medical received 11 more outperform votes than Hamilton Thorne when rated by MarketBeat users. However, 100.00% of users gave Hamilton Thorne an outperform vote while only 80.00% of users gave Quipt Home Medical an outperform vote.
Hamilton Thorne has a beta of 0.29, indicating that its stock price is 71% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 1.03, indicating that its stock price is 3% more volatile than the S&P 500.
Hamilton Thorne has a net margin of -0.90% compared to Hamilton Thorne's net margin of -1.57%. Quipt Home Medical's return on equity of -1.00% beat Hamilton Thorne's return on equity.
19.5% of Hamilton Thorne shares are owned by institutional investors. Comparatively, 45.1% of Quipt Home Medical shares are owned by institutional investors. 27.8% of Hamilton Thorne shares are owned by insiders. Comparatively, 3.8% of Quipt Home Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Summary
Hamilton Thorne and Quipt Home Medical tied by winning 9 of the 18 factors compared between the two stocks.
Get Quipt Home Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for QIPT and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QIPT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quipt Home Medical Competitors List
Related Companies and Tools
